ARCHIVES

NCI Plans Preclinical Studies Of Endoxifen, A Tamoxifen Metabolite.

This article is from The Cancer Letter archive.

Vol. 35 No. 31 | August 7, 2009

Download PDF Visit The Full Archive

Related Articles

NCI Offers Chlorozotocin

November 18, 1977

Clinical Trials Approved By NCI’s CTEP Listed

February 25, 2005

Funding Opportunities

September 20, 2002

WHI Investigators Reiterate: Breast Cancer, CHD Risks Too Great For Routine HT Use

November 2, 2002

NCI Staff Discusses New Guidelines for Core Grant Reviews, Comprehensiveness

July 24, 1992

Two Groups Take Different Approaches To Managing Toxicity Of Saltz Regimen.

June 22, 2001